Authorized generics let brand manufacturers sell their own drugs under a generic label after patent expiration. As more high-revenue drugs lose exclusivity, this strategy is evolving - with faster FDA approvals and a shift toward U.S.-made production changing how they impact prices and competition.
READ MORE